SB-275833 ointment
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SB-275833 ointment, covering 2016-09-23 to 2017-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo [Phase 3]